Le Lézard
Classified in: Health

NJ Top Doc, Dr. Indrani Hightower is Now Board Certified by The American Board of Psychiatry and Neurology


SCOTCH PLAINS, N.J., Dec. 11, 2018 /PRNewswire-PRWeb/ -- NJ Top Doc, Dr. Indrani Hightower is Now Board Certified by The American Board of Psychiatry and Neurology

NJ Top Docs has reviewed and approved Dr. Indrani Hightower of South Jersey MS Center for 2018. Dr. Hightower has recently passed the Clinical Neurophysiology Maintenance of Certification exam.

By achieving this board certification, Dr. Hightower has reached the gold standard in each of the following areas: Patient Care, Medical Knowledge, Interpersonal and Communication Skills, Professionalism, Systems-Based Practice, and Practice-Based Learning & Improvement to Practice Clinical Neurophysiology.

"It has always been my goal to improve the human brain, one synapse at a time," says Dr. Hightower.

Dr. Indrani Hightower practices at The South Jersey MS Center in Audubon, New Jersey. This practice is the largest private infusion suite in South Jersey dedicated to the comprehensive management and study of multiple sclerosis as well as preventative disease modulatory therapies. The center has recently opened another infusion suite in Linwood which uses the most up-to-date multiple sclerosis medications, including Lemtrada infusions, Ocrevus infusions, Tysabri infusions, and urgent care for multiple sclerosis flares including IV steroid infusion. As of 2019, there will also be several new multiple sclerosis medications available, they are currently in phase III clinical trials.

Dr. Hightower and the team at the South Jersey MS Center have initiated treatment with injectable medications which can result in a 50-70% reduction in rate of refractory migraine headaches. They also provide acute treatment for patients having severe migraines and provide migraine protocol infusions which are individualized to the patient in status migrainosus.

To learn more about Dr. Hightower and the South Jersey MS Center, please click here.

About Us

NJ Top Docs a comprehensive, trusted and exclusive healthcare resource featuring reviewed and approved Top Doctors and Dentists in New Jersey online in an easy to use format. NJ Top Docs only reviews and approves providers based on merit after they have been extensively vetted.

NJ Top Docs is a division of USA Top Docs which allows patients to meet providers online before making their appointment.

For more information, please click here to contact us or visit http://www.NJTopDocs.com.

You can also follow us on Facebook and Twitter

SOURCE NJ Top Docs


These press releases may also interest you

at 02:32
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...



News published on and distributed by: